Markers for early detection of cancer: statistical guidelines for nested case-control studies - Wikidata - wikimedia - TriplyDB

Markers for early detection of cancer: statistical guidelines for nested case-control studies

Markers for early detection of cancer: statistical guidelines for nested case-control studies

http://www.wikidata.org/entity/Q24804995

about

Individualized survival and treatment response predictions in breast cancer patients: involvements of phospho-EGFR and phospho-Her2/neu proteins Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction Statistical issues in randomized trials of cancer screening Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC Integrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer Metastasis Network-based identification of biomarkers coexpressed with multiple pathways Sources of bias in specimens for research about molecular markers for cancer Biomarkers for Early Cancer Detection - Methodological Aspects.Comparison of approaches to estimate confidence intervals of post-test probabilities of diagnostic test results in a nested case-control study Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.Cross-validation and Peeling Strategies for Survival Bump Hunting using Recursive Peeling Methods Markers of field cancerization: proposed clinical applications in prostate biopsies Semiparametric methods for evaluating risk prediction markers in case-control studies.DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer Evaluating markers for the early detection of cancer: overview of study designs and methods.R package PRIMsrc: Bump Hunting by Patient Rule Induction Method for Survival, Regression and Classification.Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.Using microarrays to study the microenvironment in tumor biology: the crucial role of statistics.The state of molecular biomarkers for the early detection of lung cancer.Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.Improving the biomarker pipeline to develop and evaluate cancer screening tests Better cancer biomarker discovery through better study design.Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Network Medicine: New Paradigm in the -Omics Era.Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.Cross-Validation of Survival Bump Hunting by Recursive Peeling Methods.TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention.Prognostic value of routine laboratory variables in prediction of breast cancer recurrence A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.A modified risk set approach to biomarker evaluation studies.RE: Leveraging Biospecimen Resources for Discovery or Validation of Markers for Early Cancer Detection.Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients.

P2860

Q23916643-3AFCE689-863E-4D59-885B-69567AAE321E Q23924046-4B1F98E2-8AE6-4200-B43D-665A3A865CD9 Q24791454-EE29649D-3297-48BB-95BA-F312924A73F0 Q26752611-C6A8115C-B7BC-4BE0-9D98-B1D84F389385 Q27311994-7484623D-FCBE-426A-A870-32F7991047E1 Q28387995-191359F9-22CC-475E-969A-7486587FF309 Q28397049-0353C674-914D-4C3A-BE1F-18F518DC2962 Q28397059-DB719F35-57A8-4498-AEDB-46D5911EC1EF Q33628822-0E787347-F397-4AB5-909C-E41A060335A3 Q34095989-E48061B4-617A-4824-9F78-BA8D93F89C4C Q34462793-0D8ADF21-A60F-460D-BFF7-9C3966127DAA Q34609551-076F4694-02AC-4349-B905-9413344C4D95 Q34955612-BC2D6286-B18B-4607-BFE2-BE605A6BB2D0 Q35096945-97E2D927-18E5-4730-9695-4A80E648EA4A Q35597463-B472B65A-1C5C-4BD9-8B92-E771A7F1DB5D Q35742690-A32483D7-5EBB-4E56-A535-7743D10FBE91 Q35976189-636BF152-4DEB-48DF-9034-0CB53EF29EEA Q35991148-FB67AF5B-B418-49DE-82EC-D8248E0D06BC Q36022781-84BE33A3-5F55-42FC-8F72-864E6EC14B49 Q36406332-F9C65A87-2B12-40FF-9679-E61DEC2A8F51 Q36421984-EA1F692B-927C-4D31-B0EF-84186F24E69E Q36479078-AB3A0F26-ACEF-4A68-9175-7B99AC5C45AD Q36936929-E4BBCECE-2137-4EF6-B9AB-A8BFCB53662D Q36976140-B85AF67F-BA30-4A46-98D1-A7512C9EB758 Q37044593-706F044B-137F-4C19-A55D-A5E1B90D5C20 Q37288945-4EEC0C31-2C74-455C-9AE3-0BEBDEDE1645 Q37309959-0FA101EF-F3A0-4D7A-8C0E-6DCFDC8C781F Q37310041-4A1CD322-D6B7-4C45-922B-B2DA06CFE08B Q37473332-C20959F7-3FC6-43CC-B8DD-E090ABCDC39C Q37619708-70D354B3-F436-41B5-82AC-F1ADA44B4CDD Q38258734-6C95A3A9-BA7F-4BC6-B91D-8B00757EB701 Q38763590-7AD5C2B9-17D5-479D-A366-ADECE96A8FB7 Q39101361-5568772C-B4A5-44A5-8FDA-8A5D776DB805 Q40588855-9FCBD5A3-7414-4110-BB6B-48CFD70959C6 Q40636343-F2813B4F-06A5-44B4-B492-3866263EC789 Q41421740-B8103B66-D169-446E-B953-AF974137FA4B Q41891612-0297EC16-BE3D-4299-BC84-FE64DB1FBDE3 Q42280773-0E6C86C6-6006-4687-90D1-CEA35A191BE6 Q42873653-733B6884-C326-4D77-8F79-69B0EE154E85 Q46139717-E79D4496-B399-45A7-86E1-9137694F76BF

P2860

Markers for early detection of cancer: statistical guidelines for nested case-control studies

http://www.wikidata.org/entity/Q24804995

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Markers for early detection of ...... or nested case-control studies

@ast

Markers for early detection of ...... or nested case-control studies

@en

Markers for early detection of ...... or nested case-control studies

@nl

type

label

Markers for early detection of ...... or nested case-control studies

@ast

Markers for early detection of ...... or nested case-control studies

@en

Markers for early detection of ...... or nested case-control studies

@nl

prefLabel

Markers for early detection of ...... or nested case-control studies

@ast

Markers for early detection of ...... or nested case-control studies

@en

Markers for early detection of ...... or nested case-control studies

@nl

P1433

Q24804995-862E7F18-1910-4FB6-AEED-3BFEC4430A37

P1476

Q24804995-F3F33ABF-1D74-429E-BCF8-5D0FCD106836

P2093

Q24804995-8D504812-9223-4E58-9EFA-44A9289A373A

Q24804995-B71F596B-FE73-4351-87E3-F5486B5607E7

Q24804995-EDD3107E-3ECC-49AC-B3E5-4377F76F652B

P2860

Q24804995-15DF936F-7F51-43B6-804F-D21E7EF4CE78

Q24804995-938301CC-57CD-4C77-8CD3-0FD05ED4030D

Q24804995-945A9D0A-C0A1-4E7C-886A-432007CED771

Q24804995-AB2D8ABE-09C9-4DA9-A556-E39A4DA12E42

Q24804995-D8BC4519-A57D-46AC-B0B7-D6D4758E6ACF

Q24804995-DB5A136D-C9DB-45F0-9A97-344C2A8995EB

Q24804995-DEB58C26-75C4-4CF0-9E24-202B1CDCBF32

Q24804995-E872FBA7-8C8E-4EAB-B943-F78909E51188

Q24804995-F11F98FC-1897-44E3-B342-AAE03E9BDE93

Q24804995-F34FBA6D-E5DB-484C-810B-342F2F20D524

P2888

Q24804995-73702565-F523-4F44-BC42-3C26D86FD9B5

P304

Q24804995-58495D4B-A919-48D4-861D-B4582CC0F561

P31

Q24804995-44E29150-ED15-4B36-96E4-12ACFC8B699F

P3181

Q24804995-B5BD891A-E35D-439F-A0EB-6216E8930F15

P356

Q24804995-221A859F-DBD0-4A9C-BCF0-07628895D200

P407

Q24804995-3DD4BE29-FE70-4DEC-915A-17E390D2E200

P433

Q24804995-C8C7F591-C67E-4805-8584-5080F17F3555

P478

Q24804995-C2496F26-3A76-46C8-90F7-203A20D8A7F0

P577

Q24804995-8D938135-791F-4CC9-83A9-C389EAC39D0E

P5875

Q24804995-833A7AFF-5E2D-433C-9912-701B2BDB6193

P6179

Q24804995-F7C16121-B09A-4D5C-8311-98F67736D23A

P698

Q24804995-E5509D4F-62DF-4952-A0A8-8F591CEBBCD4

P921

Q24804995-5E08696B-C626-4F23-B4F0-2B3D8D609626

P932

Q24804995-83FEFDE1-E1F7-4621-A6DB-289AF96D7CA3

P3181

P356

P1433

BMC Medical Research Methodology

P1476

Markers for early detection of ...... or nested case-control studies

@en

P2093

Barnett S Kramer

http://www.w3.org/2001/XMLSchema#string

Stuart G Baker

http://www.w3.org/2001/XMLSchema#string

Sudhir Srivastava

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring the accuracy of diagnostic systems

Phases of biomarker development for early detection of cancer.

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.

Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention.

Identifying combinations of cancer markers for further study as triggers of early intervention.

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

Regression modelling strategies for improved prognostic prediction.

Prostate cancer screening: what we know and what we need to know.

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4524951

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2288-2-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11450649

http://www.w3.org/2001/XMLSchema#string

P6179

1011873944

http://www.w3.org/2001/XMLSchema#string

P698

11914137

http://www.w3.org/2001/XMLSchema#string

P921

P932

100327

http://www.w3.org/2001/XMLSchema#string